Bipolar Disorders: Mixed States, Rapid-Cycling, and Atypical Forms

320 H. Grunze and J. WaldenBuki, V. M. and Goodnick, P. (1998). Catecholamines. In Mania. Clinical and ResearchPerspectives, ed. P. Goodnick, pp. 119–34. Washington, DC: APA Press.Calabrese, J. R., Rapport, D. J., Kimmel, S. E., et al. (1993). Rapid cycling bipolar disorder and itstreatment with valproate. Can. J. Psychiatry, 38, S57–61.Calabrese, J. R., Bowden, C. L., Sachs, G. S., et al. (1999). A double-blind placebo-controlledstudy of lamotrigine monotherapy in outpatients with bipolar I depression. J. Clin. Psychiatry,60, 79–88.Calabrese, J. R., Suppes, T., Bowden, C. L., et al. (2000). A double-blind, placebo-controlled,prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J. Clin. Psychiatry., 61,841–50.Cassidy, F., Ritchie, J. C., and Carroll, B. J., (1998). Plasma dexamethasone concentration andcortisol response during manic episodes. Biol. Psychiatry, 43, 747–54.Chang, K. D., Keck, P. E., Stanton, S. P., et al. (1998). Differences in thyroid function betweenbipolar manic and mixed states. Biol. Psychiatry, 43, 730–3.Dean, B., Pavey, G., McLeod, M., et al. (2001). A change in the density of [(3)H]flumazenil, butnot [(3)H]muscimol binding, in Brodmann’s area 9 from subjects with bipolar disorder.J. Affect. Disord., 66, 147–58.Diehl, D. J. and Gershon, S. (1992). The role of dopamine in mood disorders. Compr. Psychiatry,33, 115–20.Dunner, D. L. and Fieve, R. R. (1974). Clinical factors in lithium carbonate prophylaxis failure.Arch. Gen. Psychiatry, 30, 229–33.el Mallakh, R. S. and Wyatt, R. J. (1995). The Na, K-ATPase hypothesis for bipolar illness. Biol.Psychiatry, 37, 235–44.Evans, D. L. and Nemeroff, C. B. (1983). The dexamethasone suppression test in mixed bipolardisorder. Am. J. Psychiatry, 140, 615–17.Grunze, H., Kammerer, C., and Ackenheil, M. (1997). The neurobiology of bipolar disorder.J. Bipolar Disord., 1 2–12.Grunze, H., Schlösser, S., Amann, B., and Walden, J. (1999). Clinical research: mechanism ofaction and indications of anticonvulsants in the treatment of bipolar disorder. Dialogue Clin.Neurosci., 24–40.Grunze, H., Amann, B., Dittmann, S., and Walden, J. (2002a). Clinical relevance and treatmentpossibilities of bipolar rapid cycling. Neuropsychobiology, 45 (suppl. 1), 20–6.Grunze, H., Amann, B., and Walden, J. (2002b). How might anticonvulsant drugs workin bipolar affective disorder? In Seizures, Affective Disorders and Anticonvulsant Drugs, ed.M. R. Trimble and B. Schmitz, pp. 117–30. Guildford: Clarius Press.Hollister, L. E. and Trevino, E. S. (1999). Calcium channel blockers in psychiatric disorders: areview of the literature. Can. J. Psychiatry, 44, 658–64.Hough, C., Lu, S. J., Davis, C. L., et al. (1999). Elevated basal and thapsigargin-stimulatedintracellular calcium of platelets and lymphocytes from bipolar affective disorder patientsmeasured by a fluorometric microassay. Biol. Psychiatry, 46, 247–55.Joffe, R. T. and Sokolov, S. T. H. (1997). Hormones and bipolar affective disorder. In BipolarDisorder–Biological Models and their Clinical Application, ed. L. T. Young and R. T. Joffe,pp. 81–92. New York: Marcel Dekker.